RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.
Saved in:
| Title: | RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis. |
|---|---|
| Authors: | Elhaw AT; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania., Tang PW; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania., Cheng YY; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Kamlapurkar S; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Javed Z; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania., Al-Saad S; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., White SR; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Abdelnaby AE; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Vascular Medicine Institute (VMI), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Khan H; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Choi AS; Department of Pathology and O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Mattheyses AL; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama., Cole AR; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Kim YS; Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania.; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Atiya HI; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Trebak M; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Vascular Medicine Institute (VMI), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Zervantonakis IK; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania.; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Buckanovich RJ; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Magee Women's Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Aird KM; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Molecular and Cellular Oncogenesis Program, Ellen and Ronald Caplan Cancer Center, Wistar Institute, Philadelphia, Pennsylvania., Coffman LG; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Magee Women's Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Mythreye K; Department of Pathology and O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Hempel N; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. |
| Source: | Cancer research [Cancer Res] 2026 Jun 01; Vol. 86 (11), pp. 2623-2642. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41989584 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Elhaw+AT%22">Elhaw AT</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Tang+PW%22">Tang PW</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Cheng+YY%22">Cheng YY</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Kamlapurkar+S%22">Kamlapurkar S</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Javed+Z%22">Javed Z</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Al-Saad+S%22">Al-Saad S</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22White+SR%22">White SR</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Abdelnaby+AE%22">Abdelnaby AE</searchLink>; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Vascular Medicine Institute (VMI), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Khan+H%22">Khan H</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Choi+AS%22">Choi AS</searchLink>; Department of Pathology and O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22Mattheyses+AL%22">Mattheyses AL</searchLink>; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22Cole+AR%22">Cole AR</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Kim+YS%22">Kim YS</searchLink>; Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania.; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Atiya+HI%22">Atiya HI</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Trebak+M%22">Trebak M</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Vascular Medicine Institute (VMI), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Zervantonakis+IK%22">Zervantonakis IK</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania.; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Buckanovich+RJ%22">Buckanovich RJ</searchLink>; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Magee Women's Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Aird+KM%22">Aird KM</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Molecular and Cellular Oncogenesis Program, Ellen and Ronald Caplan Cancer Center, Wistar Institute, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Coffman+LG%22">Coffman LG</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Magee Women's Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Mythreye+K%22">Mythreye K</searchLink>; Department of Pathology and O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22Hempel+N%22">Hempel N</searchLink>; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222984705R%22">Cancer research</searchLink> [Cancer Res] 2026 Jun 01; Vol. 86 (11), pp. 2623-2642. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2984705R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-7445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200085472%22">00085472 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41989584 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/0008-5472.CAN-25-4056 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2623 Titles: – TitleFull: RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Elhaw AT – PersonEntity: Name: NameFull: Tang PW – PersonEntity: Name: NameFull: Cheng YY – PersonEntity: Name: NameFull: Kamlapurkar S – PersonEntity: Name: NameFull: Javed Z – PersonEntity: Name: NameFull: Al-Saad S – PersonEntity: Name: NameFull: White SR – PersonEntity: Name: NameFull: Abdelnaby AE – PersonEntity: Name: NameFull: Khan H – PersonEntity: Name: NameFull: Choi AS – PersonEntity: Name: NameFull: Mattheyses AL – PersonEntity: Name: NameFull: Cole AR – PersonEntity: Name: NameFull: Kim YS – PersonEntity: Name: NameFull: Atiya HI – PersonEntity: Name: NameFull: Trebak M – PersonEntity: Name: NameFull: Zervantonakis IK – PersonEntity: Name: NameFull: Buckanovich RJ – PersonEntity: Name: NameFull: Aird KM – PersonEntity: Name: NameFull: Coffman LG – PersonEntity: Name: NameFull: Mythreye K – PersonEntity: Name: NameFull: Hempel N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1538-7445 Numbering: – Type: volume Value: 86 – Type: issue Value: 11 Titles: – TitleFull: Cancer research Type: main |
| ResultId | 1 |
